NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 02 04:00PM ET
20.09
Dollar change
+0.07
Percentage change
0.35
%
CategoryTarget Date / Multi-Asset - Other Asset TypeMulti-Asset - Tactical / Active TagsGlobal Return% 1Y5.40% Total Holdings101 Perf Week0.75%
SponsorEvoke Advisors ETF Type Tagsequity Return% 3Y2.84% AUM515.79M Perf Month3.01%
Fund Family Bond Type Tagstreasuries Return% 5Y1.55% NAV/sh Perf Quarter1.72%
Index- Average Maturity Tagscommodity Return% 10Y 52W High20.79 -3.37% Perf Half Y7.39%
Index Weighting Commodity Type Tagsinflation Return% SI 52W Low17.91 12.17% Perf YTD7.52%
Active/Passive Quant Type Tags- Flows% 1M-3.85% Volatility0.66% 0.63% Perf Year5.15%
Dividend TTM0.54 (2.67%) ESG Type Tags- Flows% 3M-6.17% ATR (14)0.16 Perf 3Y1.46%
Dividend Ex-DateJun 27, 2025 Dividend Type Sector/Theme Flows% YTD-9.02% RSI (14)61.86 Perf 5Y-4.57%
Dividend Gr. 3/5Y-2.59% 58.43% Structure Type Region Flows% 1Y Beta0.70 Perf 10Y-
Expense0.50% Growth/Value SMA201.28% Flows% 3Y Rel Volume0.14 Prev Close20.02
Inverse/Leveraged Market Cap SMA502.69% Flows% 5Y Avg Volume61.57K Price20.09
IPODec 13, 2019 Option/ShortYes / Yes SMA2002.79% Trades Volume8,390 Change0.35%
RPAR Risk Parity ETF seeks to generate positive returns during periods of economic growth, preserve capital during periods of economic contraction, and preserve real rates of return during periods of heightened inflation. The fund is an actively-managed exchange-traded fund that seeks to achieve its investment objective primarily by investing across a variety of asset classes, including exposure to global equity securities, U.S. Treasury securities, and commodities. It's investment adviser seeks to invest the fund's assets to achieve exposures similar to those of the Advanced Research Risk Parity Index.